Karma Oncology

Karma Oncology is an oncology specialized, well-established unique clinical development company which was incorporated in 2012. Our flexibility and agility allow us to perform individual tasks on a clinical trial or provide full service. Our services include but are not limited to, clinical development planning, protocol preparation, site selection, regulatory submissions and project management. Quality is critical and to that end, we maintain the same team through the lifecycle of the study. Meeting timelines is as important as quality and we work closely with sponsors to ensure we work to their timelines – irrespective of time zones. Experience is critical to success and the Karma Oncology team has unmatched experience in phases I – oncology trials, i.e. from first in man through pivotal registration studies and in a wide variety of types of cancer and treatment types. Our team of professionals are known for their exceptional and extensive experience. Such experience includes both solid tumours and haematological malignancies as well as novel immunotherapy treatments such as autologous cell therapy and CAR-T therapy. Headquartered in Scotland with teams across Europe and the US we work with sponsors around the globe. In late 2017 we established a cardiology focussed sister company, Karma Cardiology, which has the same business model and services, but with a team of cardiology focussed professionals.